Email address 2:

Email address 3:

---

Web page content

Effective Vaccine

Flu Avert^® I.N. vaccine is an intranasal equine influenza vaccine that has been proven effective in actual “challenge” studies. This means horses were vaccinated with Flu Avert^® I.N. vaccine and then exposed to highly infective strains of influenza virus. The protection demonstrated by Flu Avert^® I.N. vaccine is unprecedented.

The altered virus in Flu Avert^® I.N. vaccine does not cause disease. Instead, it triggers the horse’s body to mount an impressive defense. Also, because the vaccine is given intranasally, the first response occurs in the nasal mucosa - the natural path of influenza infection. The vaccine literally stops the disease at the site of entry.

Flu Avert^® I.N. vaccine provides the highest level of influenza protection. Flu Avert^® I.N. vaccine is unique with its intranasal mode of administration. Because it is administered right at the site of infection, Flu Avert^® I.N. provides immunity faster and protects for a longer period of time – up to six months.

Flu Avert^® I.N. vaccine is best suited for horses with a high risk of exposure to influenza, including older foals, yearlings, performance horses and show horses in training and competition.

Flu Avert^® I.N., the influenza protection that works as hard as your clients’ horses. Flu Avert^® I.N. vaccine is a coldadapted, modified-live intranasal vaccine proven by challenge studies to be safe and effective against relevant North American (KY91 and KY98) and Eurasian (Sask/90) strains of equine influenza ², ³ . Flu Avert^® I.N. vaccine provides:

• Effective immunity with a single dose for up to six months.
• Reduction of clinical disease caused by equine influenza.
• Protection from clinical signs, including fever and virus shedding.

² Townsend HGG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, and Sebring RW: Efficacy of cold-adapted, intranasal, equine influenza vaccine: challenge trials.

³ Chambers TM, Holland RE, Tudor LR, Townsend HGG, Cook A, Bogdan J, Lunn DP, Hussey S, Whitaker-Dowling P, Youngner JS, Sebring RW, Penner SJ and Stiegler GL: A new modified-live equine influenza vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.